BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22594669)

  • 1. Functional social support within a medical supervised outpatient treatment program.
    Mutschler J; Eifler S; Dirican G; Grosshans M; Kiefer F; Rössler W; Diehl A
    Am J Drug Alcohol Abuse; 2013 Jan; 39(1):44-9. PubMed ID: 22594669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.
    Krampe H; Stawicki S; Wagner T; Bartels C; Aust C; Rüther E; Poser W; Ehrenreich H
    Alcohol Clin Exp Res; 2006 Jan; 30(1):86-95. PubMed ID: 16433735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experienced acetaldehyde reaction does not improve treatment response in outpatients treated with supervised disulfiram.
    Mutschler J; Dirican G; Funke S; Obermann C; Grosshans M; Mann K; Kiefer F; Diehl A
    Clin Neuropharmacol; 2011; 34(4):161-5. PubMed ID: 21677573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents.
    Niederhofer H; Staffen W
    Drug Alcohol Rev; 2003 Sep; 22(3):295-7. PubMed ID: 15385223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol.
    Helander A
    Alcohol Clin Exp Res; 1998 Feb; 22(1):111-4. PubMed ID: 9514292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series.
    Mutschler J; Grosshans M; Koopmann A; Hermann D; Diehl A; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(2):146-50. PubMed ID: 20107104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
    Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of functional social support for abstinence after inpatient detoxification].
    Mutschler J; Kobiella A; Grosshans M; Kiefer F
    Neuropsychiatr; 2010; 24(2):118-24. PubMed ID: 20605007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment.
    Fonsi Elbreder M; de Souza e Silva R; Pillon SC; Laranjeira R
    Alcohol Alcohol; 2011; 46(1):74-6. PubMed ID: 21118901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of long-term disulfiram aftercare.
    Mutschler J; Dirican G; Gutzeit A; Grosshans M
    Clin Neuropharmacol; 2011; 34(5):195-8. PubMed ID: 21881495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disulfiram in outpatient treatment of alcohol dependency].
    Hochsattel K; Brieger P
    Nervenarzt; 2016 May; 87(5):506-12. PubMed ID: 26122638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality disorders among danish alcoholics attending outpatient treatment.
    Nordholm D; Nielsen B
    Eur Addict Res; 2007; 13(4):222-9. PubMed ID: 17851244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients.
    Neto D; Lambaz R; Tavares JE
    Alcohol Alcohol; 2007; 42(6):604-9. PubMed ID: 17878216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment.
    Krampe H; Ehrenreich H
    Curr Pharm Des; 2010; 16(19):2076-90. PubMed ID: 20482514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The status of disulfiram: a half of a century later.
    Suh JJ; Pettinati HM; Kampman KM; O'Brien CP
    J Clin Psychopharmacol; 2006 Jun; 26(3):290-302. PubMed ID: 16702894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram in severe alcoholism--an open controlled study.
    Ulrichsen J; Nielsen MK; Ulrichsen M
    Nord J Psychiatry; 2010 Dec; 64(6):356-62. PubMed ID: 20297945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence.
    De Sousa AA; De Sousa J; Kapoor H
    J Subst Abuse Treat; 2008 Jun; 34(4):460-3. PubMed ID: 17629442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
    De Sousa A; De Sousa A
    Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.